Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 49
Filtrar
Más filtros

Bases de datos
País/Región como asunto
Tipo del documento
Intervalo de año de publicación
1.
Fish Physiol Biochem ; 45(4): 1495-1512, 2019 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-31001754

RESUMEN

The presence of pharmaceutical residues in the aquatic environment is receiving great attention since the levels of these substances have significantly increased in this compartment, potentially leading to adverse ecological effects. Zinc pyrithione (ZnPt) is a widely used organometallic biocide, which is incorporated into antifouling formulas, such as paints, to prevent the establishment of biofilms on surfaces exposed to the aquatic environment. It is also used in cosmetics, such as antidandruff shampoos and soaps. Considering this wide use, and the absence of a significant amount of data on the toxicity of ZnPt especially towards non-target organisms, the objective of this study was to characterize the toxicity of ZnPt, on several ecological relevant endpoints assessed in the fish Gambusia holbrooki. For this purpose, we measured traits related to feeding and aggressive behavior, as well as indicators of oxidative stress (CAT and GSTs), neurotoxicity (AChE), and anaerobic metabolism (LDH), after acute and chronic exposures to ZnPt. In terms of behavioral features, the feeding test showed the occurrence of significant differences between the control animals and those exposed to a concentration of ZnPt of 45 µg/L. In addition, ZnPt caused changes in terms of oxidative stress biomarkers (CAT and GSTs), for both exposure periods. ZnPt was also capable of causing changes in the cholinergic neurotransmission functioning and anaerobic metabolism, but only following the chronic exposure.


Asunto(s)
Ciprinodontiformes/fisiología , Desinfectantes/toxicidad , Queratolíticos/toxicidad , Compuestos Organometálicos/toxicidad , Piridinas/toxicidad , Animales , Conducta Animal/efectos de los fármacos , Contaminantes Químicos del Agua/toxicidad
2.
Br J Dermatol ; 171 Suppl 3: 34-7, 2014 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-25234176

RESUMEN

α-Hydroxy acid (AHA) formulations are commonly used for skin chemical peelings. The primary target is the stratum corneum (SC). The aim of this study was to assess the effects of various glycolic acid concentrations and commercial phenolic acid formulations on the SC. Quantitative colorimetry of a corneoxenometry bioassay was used. The test procedure involved glycolic acid concentrations ranging from 3% to 70% in alcoholic solution. Exposure times were set for 1 min and 3 min. The bioassay showed consistent reactivity with a dose-effect relationship when using the selected low exposure times. In a similar procedure the aggressiveness of commercially available phenolic acid formulations was identified not using hazardous in vivo testing. Corneoxenometry appears useful for in vitro testing of AHA peeling agents during short exposure times.


Asunto(s)
Epidermis/efectos de los fármacos , Glicolatos/toxicidad , Hidroxibenzoatos/toxicidad , Queratolíticos/toxicidad , Pruebas de Toxicidad/métodos , Relación Dosis-Respuesta a Droga , Glicolatos/administración & dosificación , Humanos , Hidroxibenzoatos/administración & dosificación , Queratolíticos/administración & dosificación , Pruebas de Toxicidad/tendencias
3.
Mutat Res ; 753(1): 42-7, 2013 Apr 30.
Artículo en Inglés | MEDLINE | ID: mdl-23474391

RESUMEN

Acitretin is currently used alone or combined with PUVA (psoralen + UVA) or with narrow-band ultraviolet B (NBUVB), to treat moderate and severe psoriasis. However, little is known about the potential genotoxic/carcinogenic risk and the cytostatic/cytotoxic effects of these treatments. Our aim was to study the cytotoxic and genotoxic effects of acitretin - alone or in combination with PUVA or NBUVB - by performing studies with blood from patients with psoriasis vulgaris who were treated with acitretin, acitretin+PUVA or acitretin+NBUVB for 12 weeks, and in vitro studies with blood from healthy volunteers, which was incubated with acitretin at different concentrations. The cytotoxic and genotoxic effects were evaluated by the cytokinesis-blocked micronucleus test and the comet assay. Our results show that psoriatic patients treated with acitretin alone or with acitretin+NBUVB, did not show genotoxic effects. In addition, these therapies reduced the rate of proliferation and induced apoptosis and necrosis of lymphocytes; the same occurred with lymphocyte cultures incubated with acitretin (1.2-20µM). The acitretin+PUVA reduced also the proliferation rate, and increased the necrotic lymphocytes. Our studies suggest that therapy with acitretin alone or combined with NBUVB, as used in psoriatic patients, does not show genotoxic effects, reduces the rate of proliferation and induces apoptosis and necrosis of lymphocytes. The combination of acitretin with PUVA also reduces the proliferation rate and increases the number of necrotic lymphocytes. However, as it induced slight genotoxic effects, further studies are needed to clarify its genotoxic potential.


Asunto(s)
Acitretina/toxicidad , Queratolíticos/toxicidad , Linfocitos/efectos de los fármacos , Metoxaleno/toxicidad , Terapia PUVA/efectos adversos , Psoriasis/tratamiento farmacológico , Fármacos Sensibilizantes a Radiaciones/toxicidad , Rayos Ultravioleta/efectos adversos , Acitretina/administración & dosificación , Acitretina/uso terapéutico , Apoptosis/efectos de los fármacos , Apoptosis/efectos de la radiación , División Celular/efectos de los fármacos , División Celular/efectos de la radiación , Terapia Combinada , Ensayo Cometa , Relación Dosis-Respuesta a Droga , Sinergismo Farmacológico , Femenino , Humanos , Queratolíticos/administración & dosificación , Queratolíticos/uso terapéutico , Linfocitos/efectos de la radiación , Masculino , Metoxaleno/administración & dosificación , Metoxaleno/uso terapéutico , Pruebas de Micronúcleos , Persona de Mediana Edad , Necrosis , Fármacos Sensibilizantes a Radiaciones/administración & dosificación , Fármacos Sensibilizantes a Radiaciones/uso terapéutico
4.
Toxicol Lett ; 341: 51-58, 2021 May 01.
Artículo en Inglés | MEDLINE | ID: mdl-33493612

RESUMEN

Palatal mesenchymal cell proliferation is essential to the process of palatogenesis, and the proliferation of mouse embryonic palate mesenchymal (MEPM) cells is impacted by both all-trans retinoic acid (atRA) and the TGF-ß/Smad signaling pathway. The long non-coding RNA (lncRNA) MEG3 has been shown to activate TGF-ß/Smad signaling and to thereby regulate cell proliferation, differentiation, and related processes. Herein, we found that atRA treatment (100 mg/kg) promoted Meg3 upregulation in MEPM cells, and that such upregulation was linked to the suppression of MEPM cell proliferation in the context of secondary palate fusion on gestational day (GD) 13 and 14. Moreover, the demethylation of specific CpG sites within the lncRNA Meg3 promoter was detected in atRA-treated MEPM cells, likely explaining the observed upregulation of this lncRNA. Smad signaling was also suppressed by atRA treatment in these cells, and RNA immunoprecipitation analyses revealed that Smad2 can directly interact with Meg3 in MEPM cells following atRA treatment. Therefore, we propose a model wherein Meg3 is involved in the suppression of MEPM cell proliferation, functioning at least in part via interacting with the Smad2 protein and thereby suppressing Smad signaling in the context of atRA-induced cleft palate.


Asunto(s)
Fisura del Paladar/inducido químicamente , ARN Largo no Codificante/metabolismo , Proteínas Smad/metabolismo , Tretinoina/efectos adversos , Animales , Fisura del Paladar/metabolismo , Femenino , Regulación del Desarrollo de la Expresión Génica/efectos de los fármacos , Queratolíticos/toxicidad , Ratones , Hueso Paladar/efectos de los fármacos , Hueso Paladar/embriología , Hueso Paladar/patología , Embarazo , ARN Largo no Codificante/genética , Proteínas Smad/genética
5.
Birth Defects Res B Dev Reprod Toxicol ; 89(6): 493-503, 2010 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-21086490

RESUMEN

Jaws are formed by cephalic neural crest (CNCCs) and mesodermal cells migrating to the first pharyngeal arch (PA1). A complex signaling network involving different PA1 components then establishes the jaw morphogenetic program. To gather insight on this developmental process, in this study, we analyze the teratogenic effects of brief (1-15 min) pulses of low doses of retinoic acid (RA: 0.25-2 µM) or RA agonists administered to early Xenopus laevis (X.l.) embryos. We show that these brief pulses of RA cause permanent craniofacial defects specifically when treatments are performed during a 6-hr window (developmental stages NF15-NF23) that covers the period of CNCCs maintenance, migration, and specification. Earlier or later treatments have no effect. Similar treatments performed at slightly different developmental stages within this temporal window give rise to different spectra of malformations. The RA-dependent teratogenic effects observed in Xenopus can be partially rescued by folinic acid. We provide evidence suggesting that in Xenopus, as in the mouse, RA causes craniofacial malformations by perturbing signaling to CNCCs. Differently from the mouse, where RA affects CNCCs only at the end of their migration, in Xenopus, RA has an effect on CNCCs during all the period ranging from their exit from the neural tube until their arrival in the PA1. Our findings provide a conceptual framework to understand the origin of individual facial features and the evolution of different craniofacial morphotypes.


Asunto(s)
Embrión no Mamífero/efectos de los fármacos , Maxilares/embriología , Queratolíticos/toxicidad , Morfogénesis/efectos de los fármacos , Cresta Neural/embriología , Tretinoina/toxicidad , Xenopus laevis/embriología , Anomalías Inducidas por Medicamentos , Animales , Benzoatos/toxicidad , Antagonismo de Drogas , Femenino , Regulación del Desarrollo de la Expresión Génica/efectos de los fármacos , Proteínas de Homeodominio/genética , Proteínas de Homeodominio/metabolismo , Hibridación in Situ , Anomalías Maxilomandibulares/inducido químicamente , Anomalías Maxilomandibulares/genética , Anomalías Maxilomandibulares/patología , Queratolíticos/administración & dosificación , Leucovorina/farmacología , Cresta Neural/anomalías , Cresta Neural/efectos de los fármacos , Quimioterapia por Pulso , Retinoides/toxicidad , Factores de Tiempo , Factores de Transcripción/genética , Factores de Transcripción/metabolismo , Tretinoina/administración & dosificación , Complejo Vitamínico B/farmacología , Proteínas de Xenopus/genética , Proteínas de Xenopus/metabolismo
6.
Pediatr Dermatol ; 26(1): 23-7, 2009.
Artículo en Inglés | MEDLINE | ID: mdl-19250400

RESUMEN

The Goeckerman regimen (GR) represents a local treatment of psoriasis and includes topical dermal application of crude coal tar (containing polycyclic aromatic hydrocarbons) and exposure to UV-irradiation. The aim of the study was to evaluate contribution of GR to genotoxic risk and cellular stress in pediatric patients who represent a sensitive population subgroup. Genotoxic risk (42 patients) was evaluated by using chromosomal aberrations (CA) in peripheral lymphocytes. Cellular stress (26 patients) was assessed by using heat shock proteins (Hsp70). All indicators were determined in blood samples collected before GR and immediately after GR. Decreasing of psoriasis area and severity index (PASI) score indicated higher likelihood of GR (p < 0.001). Significantly increased CA (p < 0.001) and Hsp70 (p < 0.05) indicated higher genotoxic risk and cellular stress in sensitive pediatric patients, immediately after GR.


Asunto(s)
Aberraciones Cromosómicas/inducido químicamente , Alquitrán/toxicidad , Queratolíticos/toxicidad , Psoriasis/tratamiento farmacológico , Psoriasis/radioterapia , Rayos Ultravioleta/efectos adversos , Administración Tópica , Adolescente , Niño , Alquitrán/administración & dosificación , Terapia Combinada , República Checa , Femenino , Proteínas HSP70 de Choque Térmico/metabolismo , Humanos , Queratolíticos/administración & dosificación , Linfocitos/metabolismo , Linfocitos/patología , Masculino , Psoriasis/epidemiología , Factores de Riesgo , Índice de Severidad de la Enfermedad , Estrés Fisiológico/efectos de los fármacos , Estrés Fisiológico/efectos de la radiación
7.
Chemosphere ; 205: 62-70, 2018 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-29684692

RESUMEN

Zinc pyrithione (ZPT) is widely used in industrial and human daily life, due to its broad antimicrobial spectrum activity. Persistent accumulation of ZTP in the aquatic environment and bioaccumulation in the living organisms attracts more and more attention. However, only very limited information is available so far for the evaluation of systematic toxicity effects of ZPT on multiple organs development. This study intends to deepen our knowledge about the potential toxicity elicited by ZPT by assessing its acute effects on zebrafish (Danio rerio) through morphological, histological and molecular investigations. It has been verified that ZPT exhibits a broad spectrum of toxicity which causes growth retardation and tissue pathological and physiology alternations in heart, liver, eye, notochord, kidney and other organisms of zebrafish. The acute toxicity values of LC50 (95% CI) 96-h is calculated as 0.073 µM. Furthermore, the organ toxicity was verified due to up-regulation of expression of biomarker genes related to organ function and development. In sum, this study demonstrats systematic acute embryological and developmental toxicity of the ZPT on zebrafish embryos/larvae.


Asunto(s)
Embrión no Mamífero/efectos de los fármacos , Queratolíticos/toxicidad , Larva/efectos de los fármacos , Hígado/efectos de los fármacos , Compuestos Organometálicos/toxicidad , Piridinas/toxicidad , Contaminantes Químicos del Agua/toxicidad , Pez Cebra/embriología , Animales , Embrión no Mamífero/citología
8.
Int J Dev Neurosci ; 68: 39-44, 2018 08.
Artículo en Inglés | MEDLINE | ID: mdl-29689339

RESUMEN

Neural tube defects (NTDs) are the most common and severe congenital malformations, which result from failure of the neural tube to close during embryonic development. The etiology of NTDs is complex, caused by interactions between genetic defects and environmental factors, but the exact mechanisms of this disease are still not fully understood. We herein employ a Seahorse Bioscience microplate-based extracellular flux (XF) analyzer to determine mitochondrial function and quantify respiratory coupling to various bioenergetic functions using specific pharmacological inhibitors of bioenergetic pathways. We demonstrate that changes in coupling between ATP turnover and proton leak are correlated with NTDs. Further, we determined that the ATP content and oxidative stress levels in posterior spinal cords of rat embryos with NTDs between E11 and E14 was lower than that of normal controls. The present study reveals that mitochondrial dysfunction is associated with all-trans retinoic acid (atRA)-induced NTDs in rat embryos. Oxidative stress results from decreased antioxidant enzyme activity. This study provides a novel viewpoint for exploring the embryonic pathogenesis of atRA-induced NTDs.


Asunto(s)
Queratolíticos/toxicidad , Enfermedades Mitocondriales/etiología , Espina Bífida Quística/inducido químicamente , Espina Bífida Quística/complicaciones , Tretinoina/toxicidad , Adenosina Trifosfato/metabolismo , Factores de Edad , Animales , Catalasa/metabolismo , Ciclooxigenasa 1/metabolismo , Embrión de Mamíferos , Regulación Enzimológica de la Expresión Génica/efectos de los fármacos , Peroxidación de Lípido/efectos de los fármacos , Consumo de Oxígeno/efectos de los fármacos , Ratas , Ratas Wistar , Médula Espinal/efectos de los fármacos , Médula Espinal/metabolismo , Superóxido Dismutasa/metabolismo
9.
Aquat Toxicol ; 78(3): 262-71, 2006 Jun 30.
Artículo en Inglés | MEDLINE | ID: mdl-16690142

RESUMEN

The acute toxicity of imidacloprid, a neonicotinoid insecticide, and zinc pyrithione (Zpt), a biocide used in anti-dandruff shampoos and protective antifouling paints, to three species of ostracods and two waterfleas, including Daphnia magna, was determined and compared under light and dark conditions. Under normal laboratory conditions, UV light had no significant influence on the outcome of toxicity bioassays, although in the case of imidacloprid both EC(50) and LC(50) calculated values were twice as high under the light as in the dark. No influence of UV light was observed on bioassays conducted with Zpt, in spite of the fast aqueous photolysis exhibited by this compound. Imidacloprid 48-h LC(50) for cladocerans (65-133mg/L) were two orders of magnitude higher than for ostracods (301-715microg/L); values of EC(50) for cladocerans and ostracods were 2-6mg/L and 3-16microg/L, respectively. Toxicity of Zpt to both ostracod and cladoceran species appears to be similar, with 48-h LC(50) in the range 137-524 and 75-197microg/L for ostracods and cladocerans, respectively, and similar values for EC(50)s. The mortality endpoint (LC(50)), however, is not a reliable predictor of the effects of imidacloprid under field situations (e.g. rice paddies), because the paralysis effect induced by this insecticide takes place at much lower concentrations than those required to cause the death of the animals: regardless of the taxa, differences as large as 100- or 600-fold were observed between the EC(50) and LC(50) for the same exposures. As a consequence, immobilization tests and EC(50) values are recommended for this class of compounds, while caution should be exercised in environmental risk assessments of this and possibly other related neonicotinoid insecticides with similar activity.


Asunto(s)
Crustáceos/efectos de los fármacos , Desinfectantes/toxicidad , Imidazoles/toxicidad , Insecticidas/toxicidad , Nitrocompuestos/toxicidad , Compuestos Organometálicos/toxicidad , Piridinas/toxicidad , Zooplancton/efectos de los fármacos , Animales , Bioensayo , Monitoreo del Ambiente , Agua Dulce , Queratolíticos/toxicidad , Dosificación Letal Mediana , Neonicotinoides , Oryza , Luz Solar , Pruebas de Toxicidad/métodos , Rayos Ultravioleta , Contaminantes Químicos del Agua/toxicidad
10.
Toxicol Sci ; 87(2): 451-9, 2005 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-16033993

RESUMEN

Oral treatment with the anti-acne drug Accutane (isotretinoin, 13-cis-retinoic acid) has been associated with suicide ideation and depression. Here, depression-like behaviors (i.e., behavioral despair and anhedonia) were quantified in adult Sprague-Dawley rats gavaged daily beginning at postnatal day (PND) 82 with 13-cis-RA (7.5 or 22.5 mg/kg) or all-trans-retinoic acid (10 or 15 mg/kg ). Tested at PND 130-131 in the Forced Swim Test, 7.5 mg/kg 13-cis-RA marginally decreased immobility and slightly increased climb/struggle durations whereas neither all-trans-retinoic acid group differed from controls. Voluntary saccharin solution (0.03%) intake at PND 102-104 and PND 151-153 was not different from controls in any treated group, although all RA-treated groups had lower intakes. Swim speed in a water maze at PND 180 was similar across groups, indicating no RA-induced differences in physical ability. Open field activity was mildly decreased at PND 91 in 7.5 mg/kg-treated males only, but it was within the control range at PND 119, 147, and 175. Thus, at serum levels similar to those in humans receiving the drug, chronic 13-cis-RA treatment did not severely affect depression-like behaviors in rats. These data do not substantiate the hypothesis of 13-cis-RA-induced depression.


Asunto(s)
Conducta Animal/efectos de los fármacos , Depresión/psicología , Isotretinoína/toxicidad , Queratolíticos/toxicidad , Tretinoina/toxicidad , Envejecimiento/psicología , Animales , Peso Corporal/efectos de los fármacos , Relación Dosis-Respuesta a Droga , Ingestión de Líquidos/efectos de los fármacos , Ingestión de Alimentos/efectos de los fármacos , Femenino , Masculino , Actividad Motora/efectos de los fármacos , Ratas , Sacarina , Caracteres Sexuales , Edulcorantes , Natación/psicología
11.
Cancer Lett ; 126(2): 135-42, 1998 Apr 24.
Artículo en Inglés | MEDLINE | ID: mdl-9585058

RESUMEN

In this communication, we report that iron overload augments benzoyl peroxide (BPO)-mediated tumor promotion in 7,12-dimethylbenz[a]anthracene (DMBA)-initiated mouse skin. Female albino Swiss mice were overloaded with iron and tumors were initiated by applying a single topical application of DMBA. A week after the initiation, promoting agent, BPO, was applied three times/week for 46 weeks. The appearance of the first tumor (papilloma) and the number of tumors/mouse were recorded. When compared to the control group, the iron-overloaded mice showed an increased incidence of tumors at various time intervals. In iron-overloaded animals, tumors appeared earlier and also the number of tumors/mouse was significantly higher. These data could be correlated with the iron levels of mouse skin in the two groups. Further, BPO-mediated induction in ornithine decarboxylase (ODC) activity and [3H]thymidine incorporation in cutaneous DNA were higher in the iron overload group. In addition, in iron-overloaded mice, cutaneous lipid peroxidation (LPO) and xanthine oxidase (XOD) activities were higher, whereas catalase activity was reduced. Similar to papilloma induction, a significant increase in carcinoma yield and incidence was observed in iron-overloaded animals. Based on this study, we propose that iron overload significantly increases the tumor promotion and progression potential of BPO. We suggest that oxidative stress generated by iron overload is responsible for the augmentation of BPO-mediated cutaneous tumorigenesis.


Asunto(s)
Peróxido de Benzoílo/toxicidad , Carcinógenos/toxicidad , Sobrecarga de Hierro/metabolismo , Hierro/efectos adversos , Queratolíticos/toxicidad , Neoplasias Cutáneas/inducido químicamente , 9,10-Dimetil-1,2-benzantraceno , Animales , Femenino , Ratones , Papiloma/inducido químicamente , Neoplasias Cutáneas/metabolismo
12.
Environ Health Perspect ; 112(14): 1341-6, 2004 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-15471723

RESUMEN

Assessment of cancer risk from exposure to polycyclic aromatic hydrocarbons (PAHs) has been traditionally conducted by applying the conservative linearized multistage (LMS) model to animal tumor data for benzo(a)pyrene (BaP), considered the most potent carcinogen in PAH mixtures. Because it has been argued that LMS use of 95% lower confidence limits on dose is unnecessarily conservative, that assumptions of low-dose linearity to zero in the dose response imply clear mechanistic understanding, and that "acceptable" cancer risk rests on a policy decision, an alternative cancer risk assessment approach has been developed. Based in part on the emerging benchmark dose (BMD) method, the modified BMD method we used involves applying a suite of conventional mathematical models to tumor dose-response data. This permits derivation of the average dose corresponding to 5% extra tumor incidence (BMD0.05) to which a number of modifying factors are applied to achieve a guideline dose, that is, a daily dose considered safe for human lifetime exposure. Application of the modified BMD method to recent forestomach tumor data from BaP ingestion studies in mice suggests a guideline dose of 0.08 microg/kg/day. Based on this and an understanding of dietary BaP, and considering that BaP is a common contaminant in soil and therefore poses human health risk via soil ingestion, we propose a BaP soil guideline value of 5 ppm (milligrams per kilogram). Mouse tumor data from ingestion of coal tar mixtures containing PAHs and BaP show that lung and not forestomach tumors are most prevalent and that BaP content cannot explain the lung tumors. This calls into question the common use of toxicity equivalence factors based on BaP for assessing risk from complex PAH mixtures. Emerging data point to another PAH compound--H-benzo(c)fluorene--as the possible lung tumorigen.


Asunto(s)
Benchmarking , Benzo(a)pireno/toxicidad , Carcinógenos Ambientales/toxicidad , Alquitrán/toxicidad , Guías como Asunto , Queratolíticos/toxicidad , Modelos Teóricos , Neoplasias/inducido químicamente , Animales , Relación Dosis-Respuesta a Droga , Ambiente , Humanos , Formulación de Políticas , Medición de Riesgo
13.
Toxicol Sci ; 50(1): 117-26, 1999 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-10445760

RESUMEN

This study sought to determine the relative roles of glycolic acid (GA), a toxicologically important metabolite of ethylene glycol (EG), and metabolic acidosis in causing developmental toxicity in Sprague-Dawley rats. To tease apart these two interrelated factors, we developed an experimental approach in which high blood glycolate levels could be achieved, in either the presence or absence of metabolic acidosis. Initially, rats previously implanted with a carotid artery cannula were given, on gestation day (gd) 10, 40.3 mmol/kg (2500 mg/kg) of EG via gavage, 8.5 mmol/kg (650 mg/kg) of GA via gavage, 8.5 mmol/kg (833 mg/kg) of sodium glycolate (NaG; pH 7.4) via subcutaneous (sc) injection, or distilled water via gavage (control). Peak serum glycolate was nearly identical (8.4-8.8 mM) in the EG, GA, and NaG groups and, as expected, EG and GA caused a metabolic acidosis, but acid base balance was normal with NaG. Subsequently, these treatments were given on gd 6-15 to groups of 25 time-mated rats, followed by fetal evaluation on gd 21. EG and GA decreased fetal body weights and caused a similar spectrum of developmental effects, including numerous axial skeleton malformations. NaG treatment also caused slight decreases in fetal body weight, increases in skeletal variations, and totally malformed fetuses. These results indicate that glycolate, in the absence of metabolic acidosis, can cause the most sensitive of EG's developmental effects, whereas metabolic acidosis appears to interact with glycolate at very high doses to markedly enhance teratogenesis. These results support previous studies, which indicated that glycolate is the proximate developmental toxicant for EG, and that GA toxicokinetic parameters can be used to define a quantitative, physiologically based threshold for EG-induced developmental effects.


Asunto(s)
Acidosis/inducido químicamente , Glicol de Etileno/metabolismo , Feto/anomalías , Glicolatos/toxicidad , Intercambio Materno-Fetal/efectos de los fármacos , Animales , Peso Corporal/efectos de los fármacos , Huesos/anomalías , Huesos/efectos de los fármacos , Glicol de Etileno/toxicidad , Femenino , Feto/efectos de los fármacos , Glicolatos/sangre , Queratolíticos/sangre , Queratolíticos/toxicidad , Masculino , Tamaño de los Órganos/efectos de los fármacos , Oxidación-Reducción/efectos de los fármacos , Embarazo , Ratas , Ratas Sprague-Dawley , Teratógenos/toxicidad , Factores de Tiempo
14.
Toxicology ; 106(1-3): 187-96, 1996 Jan 08.
Artículo en Inglés | MEDLINE | ID: mdl-8571390

RESUMEN

The human keratinocyte cell line, RHEK-1, was used to evaluate the cytotoxicity of benzoyl peroxide (BZP). As determined with the neutral red (NR) cytotoxicity assay, the 24-h midpoint (NR50) toxicity values, in mM, were 0.11 for BZP and 29.5 for benzoic acid, the stable metabolite of BZP. Irreversible cytotoxicity occurred after a 1-h exposure to 0.15 mM BZP and greater. When exposed to BZP for 7 days, a lag in growth kinetics was first observed at 0.06 mM BZP. Damage to the integrity of the plasma membrane was evident, as leakage of lactic acid dehydrogenase occurred during a 4-h exposure to BZP at 0.05 mM and greater. Intracellular membranes were also affected, as extensive vacuolization, initially perinuclear but then spreading throughout the cytoplasm, was noted in BZP-stressed cells. The generation of reactive free radicals from BZP was suggested by the following: the intracellular content of glutathione was lowered in cells exposed to BZP; cells pretreated with the glutathione-depleting agent, chlorodinitrobenzene, were hypersensitive to a subsequent challenge with BZP; lipid peroxidation by BZP was inducible in the presence of Fe2+; and cells previously maintained in a medium amended with vitamin E, an antioxidant, were more resistant to BZP, showed less lipid peroxidation in the presence of BZP+Fe2+ and did not develop the extensive intracellular vacuolization as compared to non-vitamin E maintained cells.


Asunto(s)
Peróxido de Benzoílo/toxicidad , Queratinocitos/efectos de los fármacos , Queratolíticos/toxicidad , Derivados del Benceno/toxicidad , Muerte Celular/efectos de los fármacos , División Celular/efectos de los fármacos , Línea Celular , Núcleo Celular/efectos de los fármacos , Núcleo Celular/ultraestructura , ADN/biosíntesis , Relación Dosis-Respuesta a Droga , Glutatión/metabolismo , Humanos , Queratinocitos/citología , Queratinocitos/metabolismo , L-Lactato Deshidrogenasa/metabolismo , Peroxidación de Lípido/efectos de los fármacos , Rojo Neutro , Peróxidos/toxicidad , Vacuolas/efectos de los fármacos , Vacuolas/ultraestructura , Vitamina E/farmacología , terc-Butilhidroperóxido
15.
Toxicol Lett ; 153(3): 293-302, 2004 Nov 28.
Artículo en Inglés | MEDLINE | ID: mdl-15454305

RESUMEN

The present study was carried out to study the effect of gentisic acid (2,5-dihydroxybenzoic acid (2,5-DHBA)) on the tumor promotion related events of carcinogenesis in murine skin. Benzoyl peroxide (BPO) (20 mg/0.2 ml/animal) and ultraviolet radiations (UVR) (0.420 J/m2/s) were used to induce tumor promotion response and oxidative stress and caused significant depletion in the detoxification and antioxidant enzyme armory with concomitant elevation in malondialdehyde (MDA) formation, hydrogen peroxide (H2O2) generation, ornithine decarboxylase (ODC) activity and unscheduled DNA synthesis. However, gentisic acid pretreatment at two different doses restored the levels of the above said parameters (P < 0.05) in a dose-dependent manner except in the case of ODC activity. Therefore, we propose that it might suppress the promotion stage via inhibition of oxidative stress but may not affect the polyamine biosynthetic pathway.


Asunto(s)
Peróxido de Benzoílo/antagonistas & inhibidores , Peróxido de Benzoílo/toxicidad , Gentisatos/farmacología , Queratolíticos/toxicidad , Neoplasias Inducidas por Radiación/prevención & control , Neoplasias Cutáneas/prevención & control , Animales , Catalasa/metabolismo , ADN/biosíntesis , ADN/genética , Femenino , Glucosafosfato Deshidrogenasa/metabolismo , Glutatión/metabolismo , Glutatión Peroxidasa/metabolismo , Glutatión Reductasa/metabolismo , Glutatión Transferasa/metabolismo , Peróxido de Hidrógeno/metabolismo , Peroxidación de Lípido/efectos de los fármacos , Peroxidación de Lípido/efectos de la radiación , Ratones , NAD(P)H Deshidrogenasa (Quinona)/metabolismo , Neoplasias Inducidas por Radiación/patología , Ornitina Descarboxilasa/metabolismo , Proteínas/metabolismo , Neoplasias Cutáneas/etiología , Neoplasias Cutáneas/patología , Rayos Ultravioleta
16.
Neurotoxicol Teratol ; 21(2): 141-6, 1999.
Artículo en Inglés | MEDLINE | ID: mdl-10192274

RESUMEN

Retinoic acid(RA) is a potent teratogen to which the early CNS is known to be highly sensitive. However, very little is know about the postnatal effects of RA. The cerebellum is a candidate for postnatal RA toxicity, as it develops late and exhibits temporal patterns of RA synthesis that are synchronized with developmental stages. Northern blotting shows that the cerebellum expresses receptors for RA, predominantly of the RXR group activated by 9-cis RA. To determine whether development can be disrupted by RA excess, newborn rats were injected with RA at a time when endogenous RA levels are normally low. Histological examinations at postnatal day 14 revealed loss of a subpopulation of proliferating granule cells, and adult cerebella showed clusters of ectopic granule cells located in the molecular layer. Thus, although the granule cells may normally be regulated by endogenous RA, they are sensitive to abnormally high RA concentrations.


Asunto(s)
Animales Recién Nacidos , Cerebelo/crecimiento & desarrollo , Queratolíticos/toxicidad , Tretinoina/toxicidad , Animales , Northern Blotting , Movimiento Celular/efectos de los fármacos , Cerebelo/anatomía & histología , Cerebelo/efectos de los fármacos , Femenino , Gliceraldehído-3-Fosfato Deshidrogenasas/metabolismo , Ratones , Embarazo , Ratas , Ratas Sprague-Dawley , Receptores de Ácido Retinoico/efectos de los fármacos , Receptores de Ácido Retinoico/genética
17.
Food Chem Toxicol ; 37(11): 1105-11, 1999 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-10566882

RESUMEN

The barrier integrity of hairless guinea pig skin after treatment with an alpha hydroxy acid was assessed through in vivo topical application of an oil-in-water emulsion containing 5 or 10% glycolic acid at pH 3.0. The control was a commercial moisturizing lotion, pH 7.8. A dosing regimen for the glycolic acid formulations that was tolerated by the hairless guinea pigs and significantly decreased stratum corneum turnover time was determined using the dansyl chloride staining technique. Once-daily dosing of hairless guinea pig skin for 3 weeks with the glycolic acid formulations resulted in approximately a 36-39% decrease in stratum corneum turnover time compared with the control lotion. After this treatment, hairless guinea pigs were sacrificed for the in vitro measurement of the percutaneous absorption of [14C]hydroquinone and [14C]musk xylol. No significant differences in the 24-hour absorption of either test compound were found for skin treated with the control lotion or the glycolic acid formulations. There were also no significant differences found in the absorption of [3H]water through skin from the different treatment groups. Although no increase in skin penetration occurred after treatment with the glycolic acid formulations, histology revealed approximately a twofold increase in epidermal thickness. Also the number of nucleated cell layers nearly doubled in skin treated with 5% and 10% glycolic acid compared with the control lotion and untreated skin. These studies demonstrate that substantial changes in the structure of hairless guinea pig epidermis can occur without significant effect on skin permeability of two model compounds.


Asunto(s)
Glicolatos/toxicidad , Queratolíticos/toxicidad , Absorción Cutánea/efectos de los fármacos , Administración Tópica , Animales , Compuestos de Dansilo/farmacocinética , Cobayas , Hidroquinonas/farmacocinética , Pomadas , Permeabilidad , Piel/efectos de los fármacos , Piel/metabolismo , Piel/ultraestructura , Xilenos/farmacocinética
18.
Food Chem Toxicol ; 36(9-10): 867-78, 1998.
Artículo en Inglés | MEDLINE | ID: mdl-9737434

RESUMEN

An enormous number of synthetic chemicals are incorporated in topical drugs, cosmetics and toiletries. These have the potential to cause irritant reactions when chronically applied to human skin. In predictive tests for assessing the irritancy potential of these chemicals, haired species, especially rabbits, guinea pigs and mice, have figured prominently. Customarily these tests, including the renowned Draize rabbit test, have entailed a single acute exposure or at most daily exposures over a few weeks. Estimation of inflammation and tissue injury in these models have relied on visual assessment. We submit that this approach is no longer acceptable. Visual assessments are unreliable. Reactions which are scored equivalently by the naked eye may differ strikingly when examined histologically. Moreover, tissue injury may be present in clinically normal skin. Short-term results. even when abetted by routine histological evaluations, cannot predict the degree of injury from long-term exposures. Cosmetics and toiletries, for example, are used daily for decades, often over most of the lifespan of persons who are well groomed. We present the hairless mouse as a convenient, reliable model for assessing the chronic toxicity of diverse chemicals. Histological examination enables a detailed description of the different tissue components which participate in the complex cascade of changes that comprise the inflammatory response.


Asunto(s)
Irritantes/toxicidad , Piel/efectos de los fármacos , Pruebas de Toxicidad/métodos , Administración Tópica , Animales , Peróxido de Benzoílo/administración & dosificación , Peróxido de Benzoílo/toxicidad , Carcinógenos/toxicidad , Femenino , Hidroxiácidos/administración & dosificación , Hidroxiácidos/toxicidad , Inmunohistoquímica , Irritantes/administración & dosificación , Queratolíticos/administración & dosificación , Queratolíticos/toxicidad , Ratones , Ratones Pelados , Miristatos/administración & dosificación , Miristatos/toxicidad , Inhibidores de la Síntesis del Ácido Nucleico/administración & dosificación , Inhibidores de la Síntesis del Ácido Nucleico/toxicidad , Piel/patología , Solventes/administración & dosificación , Solventes/toxicidad , Coloración y Etiquetado , Tensoactivos/administración & dosificación , Tensoactivos/toxicidad , Tretinoina/administración & dosificación , Tretinoina/toxicidad
19.
Artículo en Inglés | MEDLINE | ID: mdl-8689531

RESUMEN

Retinoic acid receptors alpha, beta and gamma (RAR alpha, beta, gamma) mRNAs from whole 8- to 15-day-old hamster fetuses were characterized and quantitated by Northern blots and solution hybridization using riboprobes from cloned hamster RAR cDNAs, derived from 12-day fetal hamster library. Two RAR alpha transcripts of approximately 3.1 and approximately 3.5 kb, one transcript of RAR beta approximately 2.8 kb and one transcript of RAR gamma approximately 3.1 kb were observed. The relative abundance levels of these transcripts were RAR gamma > beta > alpha. RAR beta and gamma levels peaked at day 11, increasing approximately 4-fold (beta) and approximately 2.5-fold (gamma) above their initial values at day 8. RAR alpha did not change appreciably and peaked on day 14 at 1.7 x of its lowest level at day 9. Regulation patterns of the three RARs diverged between days 8 and 9 and 13 and 14 postcoitum (p.c.) and coordinately increased between days 9 and 13 and decreased between days 14 and 15 p.c. In 12-day-old conceptuses exposed to all-trans-retinoic acid, RAR alpha did not increase significantly, but RAR beta increased 12-fold at 4 hr and RAR gamma 2-fold at 1 hr after the maternal treatments.


Asunto(s)
Desarrollo Embrionario y Fetal/efectos de los fármacos , Feto/química , Queratolíticos/toxicidad , Receptores de Ácido Retinoico/efectos de los fármacos , Tretinoina/toxicidad , Animales , Northern Blotting , Clonación Molecular , Cricetinae , ADN Complementario/análisis , Femenino , Embarazo , ARN Mensajero/análisis , ARN Mensajero/efectos de los fármacos , Receptores de Ácido Retinoico/análisis , Receptores de Ácido Retinoico/genética , Transcripción Genética
20.
J Toxicol Sci ; 20(3): 281-96, 1995 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-8667453

RESUMEN

The toxicity of Etretinate, a retinoid compound, on the male reproductive system was studied in male rats. The drug was administered for four weeks at the dose levels of 0 (control: Vehicle, Peanut oil), 5 and 25 mg/kg/day. The animals were then allowed to mate, and their male reproductive functions and organs were examined in detail. No significant changes due to toxicity were observed in male reproductive functions and organs in the 5 mg/kg/day group after the 4-week treatment. In contrast, males in the 25 mg/kg/day group showed drug-related changes in their reproductive performance (decrease of mating ability and fertility rate), testosterone blood level, sperm head counts, sperm viability and number in the caudal epididymis, organ weight and in the histopathology of their reproductive organs (atrophy of seminiferous tubules, necrosis of spermatocytes and spermatids, vacuolation of nuclei of spermatocytes and spermatids). Even though Etretinate belong to the retinoid group of compounds, the changes seen in the 25 mg/kg/day group were almost the same as those observed in Vitamin A-deficient animals. In conclusion, there is a correlation between changes due to toxicity observed for parameters of male fertility and for histopathological evaluation of the testis of rats that receiving high dose, treatment with Etretinate for 4 weeks.


Asunto(s)
Etretinato/toxicidad , Fertilidad/efectos de los fármacos , Animales , Peso Corporal/efectos de los fármacos , Relación Dosis-Respuesta a Droga , Esquema de Medicación , Ingestión de Alimentos/efectos de los fármacos , Etretinato/administración & dosificación , Femenino , Hormonas/sangre , Queratolíticos/administración & dosificación , Queratolíticos/toxicidad , Longevidad/efectos de los fármacos , Masculino , Tamaño de los Órganos/efectos de los fármacos , Embarazo , Ratas , Ratas Sprague-Dawley , Recuento de Espermatozoides/efectos de los fármacos , Cabeza del Espermatozoide/efectos de los fármacos , Espermatozoides/efectos de los fármacos , Testículo/efectos de los fármacos , Testículo/patología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA